Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
HNO ; 69(11): 931-942, 2021 Nov.
Artigo em Alemão | MEDLINE | ID: mdl-34643746

RESUMO

Nosebleeds (epistaxis) are usually minor. Medical intervention is only necessary in about 6% of cases. The source of bleeding is frequently located in the anterior region of the nose (Kiesselbach's plexus). The estimated lifetime prevalence of epistaxis is 60%. Diffuse epistaxis is often a manifestation of systemic disease. Epistaxis is the leading symptom of Rendu-Osler-Weber disease (hereditary hemorrhagic telangiectasia, HHT). If intervention is required, the first-choice of treatment is bidigital compression for several minutes. Common therapeutic measures include local hemostasis using electrocoagulation or chemical agents, e.g., silver nitrate. Resorbable anterior nasal tampons or tampons with a smooth surface are also frequently employed. In case of failed surgical closure of the sphenopalatine artery, angiographic embolization is the method of choice.


Assuntos
Embolização Terapêutica , Telangiectasia Hemorrágica Hereditária , Epistaxe/diagnóstico , Epistaxe/etiologia , Epistaxe/terapia , Humanos , Nariz , Telangiectasia Hemorrágica Hereditária/terapia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA